Laerke S. Gasbjerg
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 92 publications
Intravenous Oxytocin Does Not Affect Glucose-Regulating Hormones or Markers of Bone Turnover During Graded Glucose Infusion in Healthy Men.
Journal: Diabetes, obesity & metabolism
Published: June 04, 2026
Reproducibility of Splanchnic Blood Flow Measured Using Phase-Contrast MRI.
Journal: NMR in biomedicine
Published: April 16, 2026
The effect of GIP and GLP-2 on bone turnover in children with cerebral palsy or spinal muscular atrophy.
Journal: Journal of the Endocrine Society
Published: April 07, 2026
GIP contributes to postprandial regulation of splanchnic blood supply in humans with type 2 diabetes: a randomised, single-blinded, placebo-controlled, crossover study.
Journal: Diabetologia
Published: March 18, 2026
Acute GIP and GLP-1 Administration Exerts Differential Metabolic Effects in Totally Pancreatectomised Individuals.
Journal: Diabetes, obesity & metabolism
Published: March 16, 2026
Chronic, but not acute, treatment with GLP-2 and GIP in combination increases glucose absorption in the isolated vascularly perfused rat intestine.
Journal: Physiological reports
Published: February 16, 2026
A randomised clinical trial testing the safety of and metabolic responses to short-term duodenal infusion of recombinant RORDEP1 in healthy men.
Journal: Diabetologia
Published: January 09, 2026
The Glucagonotropic Effect of GIP Is Negated During Insulin-Induced Hypoglycemia in Type 1 Diabetes: A Randomized, Placebo-Controlled, Crossover Study.
Journal: Diabetes
Published: December 17, 2025
Effects of a 6-week subcutaneous infusion of native GIP alone or as add-on to semaglutide in people with type 2 diabetes: a single-centre, double-blind, parallel-group, randomised, placebo-controlled trial.
Journal: The lancet. Diabetes & endocrinology
Published: December 10, 2025
Intravenous Oxytocin Has no Effect on Ad Libitum Food Intake or Postprandial Plasma Glucose Concentrations in Individuals With Obesity: A Randomised, Placebo-Controlled, Double-Blind, Crossover Study.
Journal: Diabetes, obesity & metabolism
Published: September 30, 2025
Glucose-dependent insulinotropic polypeptide reduces postprandial glucose excursions but does not protect from hypoglycaemia in persons with type 1 diabetes-A randomised placebo-controlled study.
Journal: Diabetes, obesity & metabolism
Published: August 27, 2025
Last Updated: 09/26/2026